A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

Clinical trial NCT05235542 · COMPLETED

Trial details

NCT number: NCT05235542
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Tumors

Start date: 2022-03-12
Primary completion: 2026-05-09
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.